Gengshen Yin
Overview
Explore the profile of Gengshen Yin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang J, Yin G, Ye C, Feng M, Ji C, Zhou W, et al.
Chin J Cancer Res
. 2024 May;
36(2):124-137.
PMID: 38751436
Objective: Primary resistance to trastuzumab frequently occurs in human epidermal growth factor receptor 2 (HER2)-positive (+) breast cancer patients and remains a clinical challenge. Pyrotinib is a novel tyrosine kinase...
2.
Yin G, Liu L, Yu T, Yu L, Feng M, Zhou C, et al.
Genome Med
. 2024 Jan;
16(1):11.
PMID: 38217005
Background: Neoadjuvant chemotherapy (NAC) has become a standard treatment strategy for breast cancer (BC). However, owing to the high heterogeneity of these tumors, it is unclear which patient population most...
3.
Fan Y, Kao C, Yang F, Wang F, Yin G, Wang Y, et al.
Front Oncol
. 2022 Jun;
12:899900.
PMID: 35761863
Background: With the rapid development and wide application of high-throughput sequencing technology, biomedical research has entered the era of large-scale omics data. We aim to identify genes associated with breast...
4.
Meng X, Liu L, Xiang Y, Wang F, Yu L, Zhou F, et al.
Front Oncol
. 2022 Feb;
12:809570.
PMID: 35223490
Background: Leptin (LEP) plays a physiological role through its specific receptor (LEPR) and is involved in the occurrence and development of breast cancer. Our current study aimed at determining the...
5.
Ye C, Zhou W, Wang F, Yin G, Zhang X, Kong L, et al.
Int J Cancer
. 2021 Oct;
150(4):705-717.
PMID: 34648659
Because of the high heterogeneity of breast cancer outcome, identification of novel prognostic biomarkers is critical to improve patient stratification and guide precise treatment. We examined the prognostic value of...
6.
Zhou W, Ye C, Li L, Liu L, Wang F, Yu L, et al.
Chin J Cancer Res
. 2020 Jul;
32(3):347-360.
PMID: 32694899
Objective: Obesity is closely associated with metastasis in breast cancer patients. Secreted frizzled-related protein 5 (SFRP5), one of the novel adipokines with anti-inflammatory properties, is associated with obesity. This study...
7.
Yu L, Liu L, Wang F, Zhou F, Xiang Y, Huang S, et al.
Oncol Lett
. 2019 Mar;
17(3):2737-2744.
PMID: 30854047
The association between dairy intake and breast cancer risk has not been well investigated, especially in the Chinese population. This study aimed to examine the association between the weekly frequency...
8.
Huang S, Liu L, Xiang Y, Wang F, Yu L, Zhou F, et al.
J Cell Biochem
. 2019 Feb;
120(7):12039-12050.
PMID: 30805963
Background: Breast cancer (BC) risk, development, and prognosis were closely related to obesity, diabetes mellitus, and metabolic syndrome. Protein tyrosine phosphatase, non-receptor type 1 (PTPN1) located on chromosome 20q13, could...